These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: State of the art and further challenges. Delhaes L, Frealle E, Pinel C. Med Mycol; 2010 Nov; 48 Suppl 1():S77-87. PubMed ID: 21067334 [Abstract] [Full Text] [Related]
15. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Skov M, McKay K, Koch C, Cooper PJ. Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251 [Abstract] [Full Text] [Related]
18. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M. Am J Respir Crit Care Med; 2006 Jun 15; 173(12):1370-6. PubMed ID: 16543550 [Abstract] [Full Text] [Related]
19. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, Slavin RG, Bellone CJ. J Allergy Clin Immunol; 2000 Oct 15; 106(4):723-9. PubMed ID: 11031343 [Abstract] [Full Text] [Related]